BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 26261618)

  • 41. Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.
    Tan Z; Zhu K; Yin Y; Luo Z
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic impact of abnormally expressed, long noncoding RNAs in acute myeloid leukemia: a meta-analysis.
    Shi J; Shi X; Dai RQ
    Hematology; 2020 Dec; 25(1):219-228. PubMed ID: 33346694
    [No Abstract]   [Full Text] [Related]  

  • 43. LncRNA HOTAIR controls the expression of Rab22a by sponging miR-373 in ovarian cancer.
    Zhang Z; Cheng J; Wu Y; Qiu J; Sun Y; Tong X
    Mol Med Rep; 2016 Sep; 14(3):2465-72. PubMed ID: 27484896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA HOTTIP promotes proliferation and cell cycle progression of acute myeloid leukemia cells.
    Zhuang MF; Li LJ; Ma JB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2908-2915. PubMed ID: 31002141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [KMT2A Activates Akt/mTOR Signaling Pathway Through LncRNA-HOTAIR to Influence the Biological Behavior of AML Cells].
    Huang Y; Zhang AL; Su R; Zhang LJ; Zou R; Wang SL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):. PubMed ID: 35680797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Down-regulation of GPX3 is associated with favorable/intermediate karyotypes in de novo acute myeloid leukemia.
    Zhou JD; Wen XM; Zhang YY; Yang L; Ma YJ; Ma JC; Yang J; Guo H; Yao DM; Lin J; Qian J
    Int J Clin Exp Pathol; 2015; 8(3):2384-91. PubMed ID: 26045745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA LINP1 regulates acute myeloid leukemia progression via HNF4α/AMPK/WNT5A signaling pathway.
    Shi J; Dai R; Chen Y; Guo H; Han Y; Zhang Y
    Hematol Oncol; 2019 Oct; 37(4):474-482. PubMed ID: 31325181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic value of matrix metalloproteinase-7 and matrix metalloproteinase-15 in acute myeloid leukemia.
    Wu Y; Pan S; Leng J; Xie T; Jamal M; Yin Q; Li J; He C; Dong X; Shao L; Zhang Q
    J Cell Biochem; 2019 Jun; 120(6):10613-10624. PubMed ID: 30809850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression and effect of neuropilin-1 in acute myeloid leukemic cells].
    Lu L; Zhang L; Xiao ZJ; Lu SH; Wang GS; Yang RC; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1150-5. PubMed ID: 18088455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LINC01128 resisted acute myeloid leukemia through regulating miR-4260/NR3C2.
    Li H; Tian X; Wang P; Hu J; Qin R; Xu R; Liu K; Hao J; Tian N
    Cancer Biol Ther; 2020 Jul; 21(7):615-622. PubMed ID: 32338183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
    Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
    Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
    Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive long non-coding RNA expression profiling by RNA sequencing reveals potential biomarkers for acute myeloid leukemia risk.
    Wang Y
    Cancer Biomark; 2019; 26(1):93-108. PubMed ID: 31356197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia.
    Zhang X; Zeng J; Zhou M; Li B; Zhang Y; Huang T; Wang L; Jia J; Chen C
    Mol Cancer; 2012 Aug; 11():56. PubMed ID: 22900969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].
    Wang YG; Liu XH; Liang Y; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
    Bayram S; Sümbül AT; Dadaş E
    Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
    Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
    Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.
    Wang Y; Li Y; Song HQ; Sun GW
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7364-7370. PubMed ID: 30468482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia.
    Dzneladze I; He R; Woolley JF; Son MH; Sharobim MH; Greenberg SA; Gabra M; Langlois C; Rashid A; Hakem A; Ibrahimova N; Arruda A; Löwenberg B; Valk PJ; Minden MD; Salmena L
    Leukemia; 2015 Jul; 29(7):1485-95. PubMed ID: 25736236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
    Bertoli S; Boutzen H; David L; Larrue C; Vergez F; Fernandez-Vidal A; Yuan L; Hospital MA; Tamburini J; Demur C; Delabesse E; Saland E; Sarry JE; Galcera MO; Mansat-De Mas V; Didier C; Dozier C; Récher C; Manenti S
    Oncotarget; 2015 Nov; 6(35):38061-78. PubMed ID: 26515730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.